BeOne and Revolution Medicines partner for oncology therapies
BeOne and Revolution Medicines partner for oncology therapies is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
BeOne Medicines has signed a multi-part collaboration with Revolution Medicines to develop and commercialise targeted oncology therapies.
Source: Pharmaceutical Technology